Seven patients suffered from secondary infection of the respiratory tract infection in the treatment group ( 5 from upper respiratory tract infection and 2 from lower respiratory tract infection ) , obviously less than those of the control group ( 25 from upper respiratory tract infection and 10 from lower respiratory tract infection ) ( P < 0.05 ) .